Nicotine upregulates its own receptors through enhanced intracellular maturation
Open accessAbstract
Chronic exposure to nicotine elicits upregulation of high-affinity nicotinic receptors in the smoker's brain. To address the molecular mechanism of upregulation, we transfected HEK293 cells with human alpha4beta2 receptors and traced the subunits throughout their intracellular biosynthesis, using metabolic labeling and immunoprecipitation techniques. We show that high-mannose glycosylated subunits mature and assemble into pentamers in the endoplasmic reticulum and that only pentameric receptors reach the cell surface following carbohydrate processing. Nicotine is shown to act inside the cell and to increase the amount of beta subunits immunoprecipitated by the conformation-dependent mAb290, indicating that nicotine enhances a critical step in the intracellular maturation of these receptors. This effect, which also takes place at concentrations of nicotine found in the blood of smokers upon expression of alpha4beta2 in SH-SY5Y neuroblastoma cells, may play a crucial role in nicotine addiction and possibly implement a model of neural plasticity.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Greater β2*-nAChR availability appears attributable to occupancy of the nicotine binding site that bridges the α/β subunit interface in an immature, low-affinity conformation that facilitates glycosylation and maturation of the α4β2 nAChR to a more stable conformation with higher affinity for nicotine.
“but instead appears to be attributable to occupancy of the nicotine binding site that bridges the ␣/ subunit interface of the nAChR in an immature, low-affinity conformation that facilitates glycosylation and maturation of the ␣ 4  2 nAChR to a more stable conformation with higher affinity for nicotine (Darsow et al., 2005;Sallette et al., 2005).”
From Human Tobacco Smokers in Early Abstinence Have Higher Levels of β<sub>2</sub>* Nicotinic Acetylcholine Receptors than Nonsmokers (2006) · cites this paper as Sallette et al., 2005
Split into 2 atoms — 1 confirmed, 1 partially supported, 0 disputed, 0 misattributed, 0 unverifiable. Expand the claim to see per-atom verdicts.
Experimental — accuracy not yet measuredCurrent evidence indicates that nicotine, and presumably varenicline, raise nicotinic receptor density by promoting subunit assembly into mature receptors in the endoplasmic reticulum.
“where current evidence indicates that nicotine and presumably varenicline act to increase nAChR density by stimulating assembly of subunits into mature receptors (Sallette et al., 2004(Sallette et al., , 2005;;Kuryatov et al., 2005;Lomazzo et al., 2011;Srinivasan et al., 2011).”
From Chronic Sazetidine-A at Behaviorally Active Doses Does Not Increase Nicotinic Cholinergic Receptors in Rodent Brain (2012) · cites this paper as Sallette et al., 2005
Previous results based on glycosylation and molecular weight measures show that up-regulation is initiated in the ER.
“These data correspond with previous results based on glycosylation and molecular weight measures, showing that up-regulation is initiated in the ER (Nelson et al., 2003; Kuryatov et al., 2005; Sallette et al., 2005).”
From Nicotine up-regulates α4β2 nicotinic receptors and ER exit sites via stoichiometry-dependent chaperoning (2011) · cites this paper as Sallette et al., 2005
Descriptions that may be essentially equivalent to SePhaChARNS are the statements that nicotine acts as a maturational enhancer or a novel slow stabilizer for α4β2* receptors.
“Descriptions that may be essentially equivalent to SePhaChARNS are the statements that nicotine acts as a “maturational enhancer” or a “novel slow stabilizer” for α4β2* receptors (39,50–52).”
From Nicotine is a selective pharmacological chaperone of acetylcholine receptor number and stoichiometry. Implications for drug discovery (2009) · cites this paper as [50]
It is more likely that the quaternary drugs have sufficient membrane permeability to allow intracellular actions at the rather high concentrations (0.1-1 mM) that produce upregulation.
“however, as discussed above, it is more likely that the quaternary drugs have sufficient membrane permeability to allow intracellular actions at the rather high concentrations (0.1–1 mM) that produce upregulation (50,65,66).”
From Nicotine is a selective pharmacological chaperone of acetylcholine receptor number and stoichiometry. Implications for drug discovery (2009) · cites this paper as [50]
In previous studies on isolated cells, both agonists and antagonists can upregulate receptors.
“In previous studies on isolated cells, both agonists and antagonists can upregulate receptors (50,52,54,58,59).”
From Nicotine is a selective pharmacological chaperone of acetylcholine receptor number and stoichiometry. Implications for drug discovery (2009) · cites this paper as [50]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
ASSEMBLY OF ASPARAGINE-LINKED OLIGOSACCHARIDES
Kornfeld, R., & Kornfeld, S. A. (1985) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.54.070185.003215 · Cited by 4,863 · see citing works
Quality control in the endoplasmic reticulum
Ellgaard, L., & Helenius, A. (2003) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1052 · Cited by 2,130 · see citing works
Picciotto, M. R., Zoli, M., Rimondini, R., Léna, C., Marubio, L. M., Pich, E. M., Fuxe, K., & Changeux, J.-P. (1998) · Nature · doi:10.1038/34413 · Cited by 1,320 · see citing works
Self-citationMorello, J.-P., Salahpour, A., Laperrière, A., Bernier, V., Arthus, M., Lonergan, M., Petäjä‐Repo, U. E., Angers, S., Morin, D., Bichet, D. G., et al. (2000) · Journal of Clinical Investigation · doi:10.1172/jci8688 · Cited by 558 · see citing works
Benwell, M. E. M., Balfour, D. J. K., & Anderson, J. M. (1988) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1988.tb10600.x · Cited by 551 · see citing works
Nicotinic Cholinergic Receptor Binding Sites in the Brain: Regulation in Vivo
Schwartz, R. D., & Kellar, K. J. (1983) · Science · doi:10.1126/science.6828889 · Cited by 479 · see citing works
Effects of chronic nicotine infusion on tolerance development and nicotinic receptors
Marks, M. J., Burch, J. B., & Collins, A. C. (1983) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)21831-6 · Cited by 464 · see citing works
Alternate stoichiometries of α4β2 nicotinic acetylcholine receptors
Nelson, M. E., Kuryatov, A., Choi, C. H., Zhou, Y., & Lindstrom, J. (2003) · Molecular Pharmacology · doi:10.1124/mol.63.2.332 · Cited by 422 · see citing works
Cellular mechanisms of nicotine addiction
Dani, J. A., & De Biasi, M. (2001) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(01)00652-9 · Cited by 408 · see citing works
Peng, X., Gerzanich, V, Anand, R., Whiting, P. J., & Lindstrom, J. (1994) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)09730-5 · Cited by 391 · see citing works
Neuronal Nicotinic Acetylcholine Receptors
Lindstrom, J. (1996) · Springer eBooks · doi:10.1007/978-1-4899-1775-1_10 · Cited by 382 · see citing works
Chronic Exposure to Nicotine Upregulates the Human α4β2 Nicotinic Acetylcholine Receptor Function
Buisson, B., & Bertrand, D. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-06-01819.2001 · Cited by 361 · see citing works
Abnormal Regulation of High Affinity Nicotinic Receptors in Subjects with Schizophrenia
Breese, C. R. (2000) · Neuropsychopharmacology · doi:10.1016/s0893-133x(00)00121-4 · Cited by 343 · see citing works
Whiting, P. J., & Lindström, J. (1988) · Journal of Neuroscience · doi:10.1523/jneurosci.08-09-03395.1988 · Cited by 262 · see citing works
Nicotine addiction: the possible role of functional upregulation
Buisson, B., & Bertrand, D. (2002) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(00)01979-9 · Cited by 254 · see citing works
Merlie, J. P., & Lindstrom, J. M. (1983) · Cell · doi:10.1016/0092-8674(83)90531-7 · Cited by 205 · see citing works
Fenster, C. P., Whitworth, T. L., Sheffield, E. B., Quick, M. W., & Lester, R. A. J. (1999) · The Journal of Neuroscience · doi:10.1523/jneurosci.19-12-04804.1999 · Cited by 204 · see citing works
Lukas, R. J., Norman, S. A., & Lucero, L. M. (1993) · Molecular and Cellular Neuroscience · doi:10.1006/mcne.1993.1001 · Cited by 192 · see citing works
Peng, X.-D., Gerzanich, V., Anand, R., Wang, F., & Lindstrom, J. M. (1997) · Molecular Pharmacology · doi:10.1124/mol.51.5.776 · Cited by 191 · see citing works
Nashmi, R., Dickinson, M. E., McKinney, S., Jareb, M., Labarca, C., Fraser, S. E., & Lester, H. A. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-37-11554.2003 · Cited by 188 · see citing works
Wang, F., Nelson, M. E., Kuryatov, A., Olale, F., Cooper, J., Keyser, K., & Lindstrom, J. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.44.28721 · Cited by 187 · see citing works
Green, W. N., & Millar, N. S. (1995) · PubMed · Cited by 180 · see citing works
Gopalakrishnan, M., Monteggia, L. M., Anderson, D. J., Molinari, E. J., Piattoni-Kaplan, M., Donnelly-Roberts, D., Arneric, S. P., & Sullivan, J. P. (1996) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)12264-7 · Cited by 178 · see citing works
Acetylcholine receptor assembly: Subunit folding and oligomerization occur sequentially
Green, W. N., & Claudio, T. (1993) · Cell · doi:10.1016/0092-8674(93)90294-z · Cited by 149 · see citing works
Nguyen, H. N., Rasmussen, B. A., & Perry, D. C. (2003) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.103.056408 · Cited by 148 · see citing works
Whiteaker, P., Sharples, C. G., & Wonnacott, S. (1998) · PubMed · doi:10.7270/q2b856pt · Cited by 147 · see citing works
Green, W. N., & Millar, N. S. (1995) · Trends in Neurosciences · doi:10.1016/0166-2236(95)80009-q · Cited by 146 · see citing works
Host Cell‐Specific Folding and Assembly of the Neuronal Nicotinic Acetylcholine Receptor α7 Subunit
Cooper, S. T., & Millar, N. S. (1997) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1997.68052140.x · Cited by 140 · see citing works
Gopalakrishnan, M., Molinari, E. J., & Sullivan, J. P. (1997) · Molecular Pharmacology · doi:10.1124/mol.52.3.524 · Cited by 127 · see citing works
Smith, M. M., Lindstrom, J. M., & Merlie, J. P. (1987) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)61357-2 · Cited by 121 · see citing works
Arroyo-Jiménez, M. D. M., Bourgeois, J.-P., Marubio, L. M., Le Sourd, A.-M., Ottersen, O. P., Rinvik, E., Fairén, A., & Changeux, J.-P. (1999) · The Journal of Neuroscience · doi:10.1523/jneurosci.19-15-06475.1999 · Cited by 110 · see citing works
Self-citationRegulation of nicotinic receptor expression by the ubiquitin–proteasome system
Christianson, J. C., & Green, W. N. (2004) · The EMBO Journal · doi:10.1038/sj.emboj.7600436 · Cited by 101 · see citing works
The Role of the Cystine Loop in Acetylcholine Receptor Assembly
Green, W. N., & Wanamaker, C. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.33.20945 · Cited by 90 · see citing works
Regulation of Neuronal Function by Choline and 4OH-GTS-21 Through α7 Nicotinic Receptors
Uteshev, V. V., Meyer, E. M., & Papke, R. L. (2003) · Journal of Neurophysiology · doi:10.1152/jn.00943.2002 · Cited by 86 · see citing works
Evidence for Functional Activity of Up‐Regulated Nicotine Binding Sites in Rat Striatal Synaptosomes
Rowell, P. P., & Wonnacott, S. (1990) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1990.tb05802.x · Cited by 84 · see citing works
Nguyen, H. N., Rasmussen, B. A., & Perry, D. C. (2004) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2004.02482.x · Cited by 83 · see citing works
Sallette, J., Bohler, S., Benoit, P., Soudant, M., Pons, S., Le Novère, N., Changeux, J.-P., & Corringer, P. J. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m308260200 · Cited by 80 · see citing works
Self-citationHarkness, P. C., & Millar, N. S. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-23-10172.2002 · Cited by 74 · see citing works
Grütter, T., de Carvalho, L. P., Novère, N. G. L., Corringer, P. J., Edelstein, S. J., & Changeux, J. (2003) · The EMBO Journal · doi:10.1093/emboj/cdg197 · Cited by 64 · see citing works
Self-citationRoth, B. L., Willins, D. L., & Kroeze, W. K. (1998) · Drug and Alcohol Dependence · doi:10.1016/s0376-8716(98)00067-2 · Cited by 59 · see citing works
Berglund, U. W., Friberg, L., Gillespie, A. J., Hellström‐Lindahl, E., Zhang, X., & Nordberg, A. K. (1998) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1998.70052028.x · Cited by 46 · see citing works
Monteggia, L. M., Gopalakrishnan, M., Touma, E., Idler, K. B., Nash, N. R., Arnerić, S. P., Sullivan, J. P., & Giordano, T. (1995) · Gene · doi:10.1016/0378-1119(94)00914-e · Cited by 32 · see citing works
Grailhe, R., de Carvalho, L. P., Paas, Y., Poupon, C. L., Soudant, M., Bregestovski, P. D., Changeux, J., & Corringer, P. (2004) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2004.03153.x · Cited by 24 · see citing works
Self-citationStrecker, A., Franke, P., Weise, C., & Hucho, F. (1994) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1994.tb18705.x · Cited by 15 · see citing works
Flagged first, then by citations
2 of the 46 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Nicotinic Acetylcholine Receptors and Nicotinic Cholinergic Mechanisms of the Central Nervous System
Dani, J. A., & Bertrand, D. (2007) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.47.120505.105214 · Cited by 1,197 · see citing works
Brain nicotinic acetylcholine receptors: native subtypes and their relevance
Gotti, C., Zoli, M., & Clementi, F. (2006) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2006.07.004 · Cited by 882 · see citing works
Nicotinic receptors: allosteric transitions and therapeutic targets in the nervous system
Taly, A., Corringer, P., Guédin, D., Lestage, P. J., & Changeux, J. (2009) · Nature Reviews Drug Discovery · doi:10.1038/nrd2927 · Cited by 706 · see citing works
Self-citationStructural and functional diversity of native brain neuronal nicotinic receptors
Gotti, C., Clementi, F., Fornari, A., Gaimarri, A., Guiducci, S., Manfredi, I., Moretti, M., Pedrazzi, P., Pucci, L., & Zoli, M. (2009) · Biochemical Pharmacology · doi:10.1016/j.bcp.2009.05.024 · Cited by 469 · see citing works
Nicotine addiction and nicotinic receptors: lessons from genetically modified mice
Changeux, J.-P. (2010) · Nature Reviews Neuroscience · doi:10.1038/nrn2849 · Cited by 453 · see citing works
Self-citationPICCIOTTO, M., ADDY, N., MINEUR, Y., & BRUNZELL, D. (2008) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2007.12.005 · Cited by 451 · see citing works
Reward, addiction, withdrawal to nicotine
De Biasi, M., & Dani, J. A. (2011) · Annual Review of Neuroscience · doi:10.1146/annurev-neuro-061010-113734 · Cited by 366 · see citing works
“Other mechanisms that likely contribute to upregulation are decreased surface receptor turnover (Peng et al. 1997) and increased receptor assembly at the endoplasmic reticulum (Corringer et al. 2006; Darsow et al. 2005; Rezvani et al. 2007, 2010; Sallette et al. 2005).”
BackgroundGovind, A. P., Vezina, P., & Green, W. N. (2009) · Biochemical Pharmacology · doi:10.1016/j.bcp.2009.06.011 · Cited by 338 · see citing works
A prokaryotic proton-gated ion channel from the nicotinic acetylcholine receptor family
Bocquet, N., de Carvalho, L. P., Cartaud, J., Neyton, J., Poupon, C. L., Taly, A., Grütter, T., Changeux, J., & Corringer, P. (2006) · Nature · doi:10.1038/nature05371 · Cited by 309 · see citing works
Self-citationShi, Y., Weingarten, T. N., Mantilla, C. B., Hooten, W. M., & Warner, D. O. (2010) · Anesthesiology · doi:10.1097/aln.0b013e3181ebdaf9 · Cited by 304 · see citing works
Moroni, M., Zwart, R., Sher, E., Cassels, B. K., & Bermúdez, I. (2006) · Molecular Pharmacology · doi:10.1124/mol.106.023044 · Cited by 286 · see citing works
Nicotine acts as a pharmacological chaperone to up-regulate human α4β2 acetylcholine receptors
Kuryatov, A., Luo, J., Cooper, J., & Lindstrom, J. (2005) · Molecular Pharmacology · doi:10.1124/mol.105.012419 · Cited by 275 · see citing works
Nashmi, R., Xiao, C., Deshpande, P., McKinney, S., Grady, S. R., Whiteaker, P., Huang, Q., McClure-Begley, T., Lindstrom, J. M., Labarca, C., et al. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.2199-07.2007 · Cited by 274 · see citing works
Neuronal and Extraneuronal Nicotinic Acetylcholine Receptors
Zoli, M., Pucci, S., Vilella, A., & Gotti, C. (2018) · Current Neuropharmacology · doi:10.2174/1570159x15666170912110450 · Cited by 260 · see citing works
Exley, R. A., & Cragg, S. J. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707510 · Cited by 249 · see citing works
Marinko, J. T., Huang, H., Penn, W. D., Capra, J. A., Schlebach, J. P., & Sanders, C. R. (2019) · Chemical Reviews · doi:10.1021/acs.chemrev.8b00532 · Cited by 249 · see citing works
Why do patients with schizophrenia smoke?
Winterer, G. (2010) · Current Opinion in Psychiatry · doi:10.1097/yco.0b013e3283366643 · Cited by 238 · see citing works
Staley, J. K., Krishnan-Sarin, S., Cosgrove, K. P., Krantzler, E., Frohlich, E., Perry, E., Dubin, J. A., Estok, K., Brenner, E., Baldwin, R. M., et al. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.0546-06.2006 · Cited by 223 · see citing works
“, 2003), enhanced maturation and transport through the secretory pathway to the cell membrane (Sallette et al., 2005), increased trans-”
BackgroundInfluentialSmoking, nicotine and neuropsychiatric disorders
Döme, P., Lazáry, J., Kalapos, M. P., & Rihmer, Z. (2009) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2009.07.013 · Cited by 215 · see citing works
Neural Systems Governed by Nicotinic Acetylcholine Receptors: Emerging Hypotheses
Miwa, J. M., Freedman, R., & Lester, H. A. (2011) · Neuron · doi:10.1016/j.neuron.2011.03.014 · Cited by 205 · see citing works
Akaike, A., Takada‐Takatori, Y., Kume, T., & Izumi, Y. (2009) · Journal of Molecular Neuroscience · doi:10.1007/s12031-009-9236-1 · Cited by 200 · see citing works
Moser, N., Mechawar, N., Jones, I. W., Gochberg-Sarver, A., Orr‐Urtreger, A., Plomann, M., Salas, R., Molles, B. E., Marubio, L. M., Roth, U., et al. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.04498.x · Cited by 197 · see citing works
Self-citationRoles of Accessory Subunits in α4β2* Nicotinic Receptors
Kuryatov, A., Onksen, J., & Lindstrom, J. (2008) · Molecular Pharmacology · doi:10.1124/mol.108.046789 · Cited by 195 · see citing works
α6β2* and α4β2* Nicotinic Acetylcholine Receptors As Drug Targets for Parkinson’s Disease
Quik, M., & Wonnacott, S. (2011) · Pharmacological Reviews · doi:10.1124/pr.110.003269 · Cited by 194 · see citing works
Wang, J. C. C., Cruchaga, C., Saccone, N. L., Bertelsen, S. E., Liu, P., Budde, J., Duan, W., Fox, L. W., Grucza, R. A., Kern, J., et al. (2009) · Human Molecular Genetics · doi:10.1093/hmg/ddp231 · Cited by 187 · see citing works
Srinivasan, R., Pantoja, R., Moss, F. J., Mackey, E. D. W., Son, C. D., Miwa, J., & Lester, H. A. (2011) · Journal of General Physiology · doi:10.1085/jgp.201010532 · Cited by 169 · see citing works
Alteration of the in vivo nicotinic receptor density in ADNFLE patients: a PET study
Picard, F., Bruel, D., Servent, D., Saba, W., Fruchart‐Gaillard, C., Peyronneau, M., Roumenov, D., Brodtkorb, E., Zuberi, S. M., Gambardella, A., et al. (2006) · Brain · doi:10.1093/brain/awl156 · Cited by 168 · see citing works
Lester, H. A., Xiao, C., Srinivasan, R., Son, C. D., Miwa, J., Pantoja, R., Banghart, M. R., Dougherty, D. A., Goate, A. M., & Wang, J. C. (2009) · The AAPS Journal · doi:10.1208/s12248-009-9090-7 · Cited by 163 · see citing works
Cosgrove, K. P., Batis, J., Bois, F., Maciejewski, P. K., Esterlis, I., Kloczynski, T., Stiklus, S., Krishnan-Sarin, S., O’Malley, S., Perry, E., et al. (2009) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2009.41 · Cited by 159 · see citing works
Nicotinic receptor agonists as neuroprotective/neurotrophic drugs. Progress in molecular mechanisms
Mudò, G., Belluardo, N., & Fuxé, K. (2006) · Journal of Neural Transmission · doi:10.1007/s00702-006-0561-z · Cited by 156 · see citing works
Exposure to nicotine and sensitization of nicotine-induced behaviors
Vezina, P., McGehee, D. S., & Green, W. N. (2007) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2007.08.038 · Cited by 151 · see citing works
Song, P., Sekhon, H. S., Lu, A., Arredondo, J., Sauer, D., Gravett, C. A., Mark, G. P., Grando, S. A., & Spindel, E. R. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-2484 · Cited by 149 · see citing works
Mechanisms of Action and Persistent Neuroplasticity by Drugs of Abuse
Korpi, E. R., den Hollander, B., Farooq, U., Vashchinkina, E., Rajkumar, R., Nutt, D. J., Hyytiä, P., & Dawe, G. S. (2015) · Pharmacological Reviews · doi:10.1124/pr.115.010967 · Cited by 148 · see citing works
AMPA receptor biogenesis and trafficking
Greger, I. H., & Esteban, J. A. (2007) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2007.04.007 · Cited by 145 · see citing works
Nicotine and serotonin in immune regulation and inflammatory processes: a perspective
Cloëz-Tayarani, I., & Changeux, J. (2006) · Journal of Leukocyte Biology · doi:10.1189/jlb.0906544 · Cited by 145 · see citing works
Self-citationAssembly and trafficking of nicotinic acetylcholine receptors (Review)
Millar, N. S., & Harkness, P. C. (2008) · Molecular Membrane Biology · doi:10.1080/09687680802035675 · Cited by 142 · see citing works
Mao, D., Perry, D. C., Yasuda, R. P., Wolfe, B. B., & Kellar, K. J. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.05011.x · Cited by 133 · see citing works
Striatal α6* Nicotinic Acetylcholine Receptors: Potential Targets for Parkinson’s Disease Therapy
Quik, M., & McIntosh, J. M. (2006) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.105.094375 · Cited by 127 · see citing works
RIC‐3: a nicotinic acetylcholine receptor chaperone
Millar, N. S. (2008) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707661 · Cited by 125 · see citing works
Carbone, A., Moroni, M., Groot-Kormelink, P., & Bermúdez, I. (2009) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2008.00104.x · Cited by 123 · see citing works
Biogenesis, trafficking and up-regulation of nicotinic ACh receptors
Colombo, S. F., Mazzo, F., Pistillo, F., & Gotti, C. (2013) · Biochemical Pharmacology · doi:10.1016/j.bcp.2013.06.023 · Cited by 118 · see citing works
Govind, A. P., Walsh, H., & Green, W. N. (2012) · Journal of Neuroscience · doi:10.1523/jneurosci.5438-11.2012 · Cited by 116 · see citing works
Xiao, C., Nashmi, R., McKinney, S. L., Cai, H., McIntosh, J. M., & Lester, H. A. (2009) · Journal of Neuroscience · doi:10.1523/jneurosci.2939-09.2009 · Cited by 115 · see citing works
Richard, M., Boulin, T., Robert, V. J. P., Richmond, J. E., & Bessereau, J. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1216154110 · Cited by 114 · see citing works
Nicotine regulates multiple synaptic proteins by inhibiting proteasomal activity
Rezvani, K., Teng, Y., Shim, D., & De Biasi, M. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.3353-07.2007 · Cited by 113 · see citing works
Allosteric Receptors: From Electric Organ to Cognition
Changeux, J. (2010) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.010909.105741 · Cited by 109 · see citing works
Self-citationMolecular and Cellular Mechanisms of Action of Nicotine in the CNS
Barik, J., & Wonnacott, S. (2009) · Handbook of experimental pharmacology · doi:10.1007/978-3-540-69248-5_7 · Cited by 108 · see citing works
Perry, D. C., Mao, D., Gold, A. B., McIntosh, J. M., Pezzullo, J. C., & Kellar, K. J. (2007) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.107.121228 · Cited by 106 · see citing works
Mitochondria as a possible target for nicotine action
Malińska, D., Wieckowski, M. R., Michalska, B., Drabik, K., Prill, M., Patalas‐Krawczyk, P., Walczak, J., Szymański, J., Mathis, C., van der Toorn, M., et al. (2019) · Journal of Bioenergetics and Biomembranes · doi:10.1007/s10863-019-09800-z · Cited by 103 · see citing works
Pharmacological chaperoning: A primer on mechanism and pharmacology
Leidenheimer, N. J., & Ryder, K. G. (2014) · Pharmacological Research · doi:10.1016/j.phrs.2014.01.005 · Cited by 102 · see citing works
Inside-out neuropharmacology of nicotinic drugs
Henderson, B. J., & Lester, H. A. (2015) · Neuropharmacology · doi:10.1016/j.neuropharm.2015.01.022 · Cited by 102 · see citing works
Differential Regulation of α7 Nicotinic Receptor Gene (CHRNA7) Expression in Schizophrenic Smokers
Mexal, S., Berger, R., Logel, J., Ross, R. G., Freedman, R., & Leonard, S. S. (2009) · Journal of Molecular Neuroscience · doi:10.1007/s12031-009-9233-4 · Cited by 100 · see citing works
Quik, M., Perez, X. A., & Grady, S. R. (2011) · Biochemical Pharmacology · doi:10.1016/j.bcp.2011.06.001 · Cited by 94 · see citing works
The relationship between nicotine and psychosis
Quigley, H., & MacCabe, J. H. (2019) · Therapeutic Advances in Psychopharmacology · doi:10.1177/2045125319859969 · Cited by 90 · see citing works
Regulation of neuronal nicotinic receptor traffic and expression
Gaimarri, A., Moretti, M., Riganti, L., Zanardi, A., Clementi, F., & Gotti, C. (2007) · Brain Research Reviews · doi:10.1016/j.brainresrev.2007.02.005 · Cited by 89 · see citing works
Long-term consequences of maternal smoking and developmental chronic nicotine exposure
Ursula, H. W.-S. (2007) · Frontiers in bioscience · doi:10.2741/2708 · Cited by 89 · see citing works
Sun, H., Liu, X., Xiong, Q., Shikano, S., & Li, M. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m600072200 · Cited by 87 · see citing works
Corringer, P.-J., Sallette, J., & Changeux, J.-P. (2006) · Journal of Physiology-Paris · doi:10.1016/j.jphysparis.2005.12.012 · Cited by 86 · see citing works
Self-citationThe concept of allosteric modulation: an overview
Changeux, J. (2012) · Drug Discovery Today Technologies · doi:10.1016/j.ddtec.2012.07.007 · Cited by 86 · see citing works
Self-citationRow, B. W., Kheirandish, L., Cheng, Y.-S., Rowell, P. P., & Gozal, D. (2007) · Behavioural Brain Research · doi:10.1016/j.bbr.2006.11.028 · Cited by 84 · see citing works
Henderson, B. J., Wall, T. R., Henley, B. M., Kim, C. H., Nichols, W. A., Moaddel, R., Xiao, C., & Lester, H. A. (2016) · Journal of Neuroscience · doi:10.1523/jneurosci.4194-15.2016 · Cited by 79 · see citing works
Molecular Mechanisms Regulating LPS-Induced Inflammation in the Brain
Lykhmus, O., Mishra, N., Koval, L., Kalashnyk, O., Gergalova, G., Uspenska, K., Комісаренко, С. В., Soreq, H., & Skok, M. (2016) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2016.00019 · Cited by 79 · see citing works
Nicotine exploits a COPI-mediated process for chaperone-mediated up-regulation of its receptors
Henderson, B. J., Srinivasan, R., Nichols, W. A., Dilworth, C. N., Gutierrez, D. F., Mackey, E. D. W., McKinney, S., Drenan, R. M., Richards, C. I., & Lester, H. A. (2014) · Journal of General Physiology · doi:10.1085/jgp.201311102 · Cited by 78 · see citing works
Perez, X. A., Bordia, T., McIntosh, J. M., Grady, S. R., & Quik, M. (2008) · Molecular Pharmacology · doi:10.1124/mol.108.048843 · Cited by 77 · see citing works
Doyon, W. M., Thomas, A. M., Ostroumov, A., Dong, Y., & Dani, J. A. (2013) · Biochemical Pharmacology · doi:10.1016/j.bcp.2013.07.007 · Cited by 77 · see citing works
Tumkosit, P., Kuryatov, A., Luo, J., & Lindstrom, J. (2006) · Molecular Pharmacology · doi:10.1124/mol.106.027326 · Cited by 73 · see citing works
Partial agonists as therapeutic agents at neuronal nicotinic acetylcholine receptors
Hogg, R. C., & Bertrand, D. (2006) · Biochemical Pharmacology · doi:10.1016/j.bcp.2006.08.010 · Cited by 72 · see citing works
Marks, M. J., McClure-Begley, T. D., Whiteaker, P., Salminen, O., Brown, R. W. B., Cooper, J., Collins, A. C., & Lindstrom, J. M. (2011) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.110.178236 · Cited by 70 · see citing works
Live-Cell Imaging of Single Receptor Composition Using Zero-Mode Waveguide Nanostructures
Richards, C. I., Luong, K., Srinivasan, R., Turner, S. W., Dougherty, D. A., Korlach, J., & Lester, H. A. (2012) · Nano Letters · doi:10.1021/nl301480h · Cited by 68 · see citing works
Pharmacological chaperoning of nAChRs: A therapeutic target for Parkinson's disease
Srinivasan, R., Henderson, B. J., Lester, H. A., & Richards, C. I. (2014) · Pharmacological Research · doi:10.1016/j.phrs.2014.02.005 · Cited by 67 · see citing works
Srinivasan, R., Richards, C. I., Xiao, C., Rhee, D., Pantoja, R., Dougherty, D. A., Miwa, J. M., & Lester, H. A. (2012) · Molecular Pharmacology · doi:10.1124/mol.112.077792 · Cited by 66 · see citing works
Kabbani, N., Woll, M. P., Levenson, R. G., Lindstrom, J. M., & Changeux, J. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0710314104 · Cited by 64 · see citing works
Self-citationMugnaini, M., Garzotti, M., Sartori, I., Pilla, M. A., Repeto, P., Heidbreder, C. A., & Tessari, M. (2005) · Neuroscience · doi:10.1016/j.neuroscience.2005.09.008 · Cited by 64 · see citing works
Cognitive Deficits in Schizophrenia: Focus on Neuronal Nicotinic Acetylcholine Receptors and Smoking
Ochoa, E. L. M., & Lasalde‐Dominicci, J. A. (2007) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-007-9149-x · Cited by 64 · see citing works
Assembly of nicotinic and other Cys‐loop receptors
Tsetlin, V. I., Kuzmin, D., & Kasheverov, I. E. (2011) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2010.07060.x · Cited by 63 · see citing works
Evidence for a role of nicotinic acetylcholine receptors in schizophrenia
Catherine, E. A. (2007) · Frontiers in bioscience · doi:10.2741/2424 · Cited by 63 · see citing works
Pandya, A. A., & Yakel, J. L. (2013) · Biochemical Pharmacology · doi:10.1016/j.bcp.2013.05.018 · Cited by 62 · see citing works
Zhang, Y., Cao, S.-X., Sun, P., He, H.-Y., Yang, C.-H., Chen, X., Shen, C.-J., Wang, X., Chen, Z., Berg, D. K., et al. (2016) · Cell Research · doi:10.1038/cr.2016.48 · Cited by 62 · see citing works
Determining the pharmacokinetics of nicotinic drugs in the endoplasmic reticulum using biosensors
Shivange, A. V., Borden, P. M., Muthusamy, A. K., Nichols, A. L., Bera, K., Bao, H., Bishara, I., Jeon, J., Mulcahy, M. J., Cohen, B. N., et al. (2019) · The Journal of General Physiology · doi:10.1085/jgp.201812201 · Cited by 62 · see citing works
Addiction‐related neuroadaptations following chronic nicotine exposure
Wills, L., & Kenny, P. J. (2021) · Journal of Neurochemistry · doi:10.1111/jnc.15356 · Cited by 61 · see citing works
Srinivasan, R., Henley, B. M., Henderson, B. J., Indersmitten, T., Cohen, B. N., Kim, C. H., McKinney, S. L., Deshpande, P., Xiao, C., & Lester, H. A. (2016) · Journal of Neuroscience · doi:10.1523/jneurosci.2126-15.2016 · Cited by 61 · see citing works
Principles of agonist recognition in Cys-loop receptors
Lynagh, T., & Pless, S. A. (2014) · Frontiers in Physiology · doi:10.3389/fphys.2014.00160 · Cited by 60 · see citing works
Tropak, M. B., & Mahuran, D. J. (2007) · FEBS Journal · doi:10.1111/j.1742-4658.2007.06040.x · Cited by 60 · see citing works
Ubiquilin-1 Regulates Nicotine-induced Up-regulation of Neuronal Nicotinic Acetylcholine Receptors
Ficklin, M. B., Zhao, S., & Feng, G. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m506781200 · Cited by 59 · see citing works
Son, C. D., Moss, F. J., Cohen, B. N., & Lester, H. A. (2009) · Molecular Pharmacology · doi:10.1124/mol.108.054494 · Cited by 58 · see citing works
Wada, T., Naito, M., Kenmochi, H., Tsuneki, H., & Sasaoka, T. (2006) · Endocrinology · doi:10.1210/en.2006-0907 · Cited by 58 · see citing works
Conduits of Life’s Spark: A Perspective on Ion Channel Research since the Birth of Neuron
Isacoff, E. Y., Jan, L. Y., & Minor, D. L. (2013) · Neuron · doi:10.1016/j.neuron.2013.10.040 · Cited by 57 · see citing works
Gogliettino, A. R., Potenza, M. N., & Yip, S. W. (2016) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2016.02.015 · Cited by 56 · see citing works
Crystal Structure of the Extracellular Domain of a Bacterial Ligand-Gated Ion Channel
Nury, H., Bocquet, N., Poupon, C. L., Raynal, B. D. E., Haouz, A., Corringer, P., & Delarue, M. H. (2009) · Journal of Molecular Biology · doi:10.1016/j.jmb.2009.11.024 · Cited by 56 · see citing works
Self-citationAvelar, A. J., Akers, A. T., Baumgard, Z. J., Cooper, S. Y., Casinelli, G. P., & Henderson, B. J. (2019) · Neuropharmacology · doi:10.1016/j.neuropharm.2019.107729 · Cited by 56 · see citing works
Nicotine-Modulated Subunit Stoichiometry Affects Stability and Trafficking of 3 4 Nicotinic Receptor
Mazzo, F., Pistillo, F., Grazioso, G., Clementi, F., Borgese, N., Gotti, C., & Colombo, S. F. (2013) · Journal of Neuroscience · doi:10.1523/jneurosci.2393-13.2013 · Cited by 55 · see citing works
Nicotinic acetylcholine receptors: upregulation, age‐related effects and associations with drug use
Melroy-Greif, W. E., Stitzel, J. A., & Ehringer, M. A. (2015) · Genes Brain & Behavior · doi:10.1111/gbb.12251 · Cited by 54 · see citing works
Trafficking of α4* Nicotinic Receptors Revealed by Superecliptic Phluorin
Richards, C. I., Srinivasan, R., Xiao, C., Mackey, E. D. W., Miwa, J. M., & Lester, H. A. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.256024 · Cited by 54 · see citing works
Modifiable risk factors for incidence of pain in older adults
Shi, Y., Hooten, W. M., Roberts, R. O., & Warner, D. O. (2010) · Pain · doi:10.1016/j.pain.2010.07.021 · Cited by 54 · see citing works
Neurophysiology of Nicotine Addiction
Dani, J. A., Jenson, D., & Broussard, J. I. (2012) · Journal of Addiction Research & Therapy · doi:10.4172/2155-6105.s1-001 · Cited by 53 · see citing works
Psychiatric Drugs Bind to Classical Targets Within Early Exocytotic Pathways: Therapeutic Effects
Lester, H. A., Miwa, J. M., & Srinivasan, R. (2012) · Biological Psychiatry · doi:10.1016/j.biopsych.2012.05.020 · Cited by 53 · see citing works
Takada‐Takatori, Y., Kume, T., Izumi, Y., Ohgi, Y., Niidome, T., Fujii, T., Sugimoto, H., & Akaike, A. (2009) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.32.318 · Cited by 53 · see citing works
The α4 Nicotinic Receptor Promotes CD4+ T-Cell Proliferation and a Helper T-Cell Immune Response
Nordman, J. C., Muldoon, P. P., Clark, S. G., Damaj, M. I., & Kabbani, N. (2013) · Molecular Pharmacology · doi:10.1124/mol.113.088484 · Cited by 53 · see citing works
Pharmacological folding chaperones act as allosteric ligands of Frizzled4
Generoso, S., Giustiniano, M., Regina, G. L., Bottone, S., Passacantilli, S., Maro, S. D., Cassese, H., Bruno, A., Mallardo, M., Dentice, M., et al. (2015) · Nature Chemical Biology · doi:10.1038/nchembio.1770 · Cited by 52 · see citing works
Huang, L. Z., & Winzer‐Serhan, U. H. (2006) · Brain Research · doi:10.1016/j.brainres.2006.06.084 · Cited by 52 · see citing works
- Authors
- Sallette, J., Pons, S., Devillers-Thiery, A., Soudant, M., Prado de Carvalho, L., Changeux, J.-P., & Corringer, P. J.
- Affiliations
- Centre National de la Recherche Scientifique (FR)
- Corresponding author
- Changeux, Jean-Pierre
- Corringer, Pierre Jean
- Venue
- Neuron
- Publisher
- Elsevier BV
- Published
- 2005-05
- Volume
- 46
- Issue
- 4
- Pages
- 595-607
- ISSN
- 0896-6273 (ISSN-L)
- OpenAlex
- W1994720205
- Cited by
- 261
- References
- 46
- Citations by year
- 2025: 4 · 2024: 3 · 2023: 5 · 2022: 3 · 2021: 3 · 2020: 6 · 2019: 8 · 2018: 6 · 2017: 11 · 2016: 17 · 2015: 11 · 2014: 18 · 2013: 19 · 2012: 16
- FWCI
- 7.78
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- www.elsevier.com/open-access/userlicense/1.0/ (vor, 2999 d)
- doi.org/10.15223/policy-017 (stm-asf)
- doi.org/10.15223/policy-037 (stm-asf)
- doi.org/10.15223/policy-012 (stm-asf)
- doi.org/10.15223/policy-029 (stm-asf)
- doi.org/10.15223/policy-004 (stm-asf)
- Locations
- Neuron (publishedVersion)
- PubMed (publishedVersion)
- HAL (submittedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nicotinic Acetylcholine Receptors Study
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Receptor Mechanisms and Signaling
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Keywords
- nicotine, nicotinic acetylcholine receptors, alpha4beta2 receptor, receptor up-regulation, glycosylation, high-mannose glycosylation, endoplasmic reticulum, receptor trafficking, nicotine dependence, neuroplasticity
- MeSH terms
- Antibodies, Autoradiography, Binding, Competitive, Carbachol, Cell Line, Dihydro-beta-Erythroidine, Dose-Response Relationship, Drug, Drug Interactions, Fluorescent Antibody Technique, Glycosylation, Humans, Membrane Potentials, Models, Biological, Nicotine, Protein Binding, Pyridines, Receptors, Nicotinic, Time Factors, Transfection, Tritium, Blotting, Western, Up-Regulation, Patch-Clamp Techniques, Nicotinic Agonists, Nicotinic Antagonists, Bridged Bicyclo Compounds, Heterocyclic, Protein Subunits, Intracellular Space, Immunoprecipitation
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review